Advancing precision medicine for ovarian granulosa cell tumours
This month, the ovarian cancer research program at the Hudson Institute of Medical Research, in a collaboration with Monash Health, was awarded $2.2 million from [...]
MPCCC research partnership with Monash BDI to improve future accuracy of precision medicine
A new MPCCC partnership with Monash University’s Biomedicine Discovery Institute (Monash BDI) will investigate whether innovative research technologies, including multi-omic and organoid profiling, can improve the [...]
A health economics perspective on comprehensive genome profiling
On 3 April 2020, MPCCC hosted its first online Precision Oncology Seminar, presented by health economics expert Professor Maarten IJzerman during which he presented his [...]
Victoria’s approach to managing cancer during COVID-19
MPCCC has joined forces with the Victorian Comprehensive Cancer Centre (VCCC) alliance to help Victoria’s front line clinical teams adjust to managing cancer prevention, treatment [...]
COVID-19 may leave a lasting telehealth legacy for Victorian cancer care
Telehealth has become a vital tool for the care and safety of cancer patients during COVID-19 and has highlighted a variety of sustainable opportunities for [...]
Victoria launches Safe Cancer Care campaign for patients
Cancer patients will receive clear messaging and information about the importance and safety of their care during COVID-19 with the launch of the new Safe [...]
MPCCC announces inaugural Award for Outstanding Cancer Research
The MPCCC will recognise the achievements of innovative and impactful Victorian mid-career cancer researchers, with the presentation of its inaugural 2020 Award for Outstanding Cancer [...]
Victorian COVID-19 Cancer Network launches
MPCCC has joined forces with the Victorian Comprehensive Cancer Centre (VCCC) to coordinate a response to COVID-19. A new collaborative platform will help health professionals respond [...]
Precision Oncology advanced by international landmark study
Cancer patients are likely to benefit from more targeted treatments following work that has increased the number of identifiable cancer genome signatures to 97. The [...]
National collaboration to increase local cancer patients’ access to affordable genetic testing
Cancer patients treated in Victoria will benefit from more affordable access to molecular tumour profiling, following a new collaboration between the Australian Genomic Cancer Medicine [...]